Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Paterson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal for Immunotherapy of Cancer|April 30, 2020
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32aMarisa O Peluso, Ammar Adam, Caroline M Armet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivoJun Yang, Leonardo V Riella, Susanne Chock, et al.
JCI Insight|November 9, 2021
Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanismsThiago J Borges, Naoka Murakami, Isadora T Lape, et al.
Elife|May 23, 2015
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cellsBernard Khor, John D Gagnon, Gautam Goel, et al.
Journal of Hematology & Oncology|January 4, 2026
CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignanciesStephen J F Chong, Rebecca Valentin, Jing Wang, et al.
Science (New York, N.Y.)|July 3, 2025
Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognitionGeorg Petzold, Pablo Gainza, Stefano Annunziato, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal for Immunotherapy of Cancer|April 30, 2020
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32aMarisa O Peluso, Ammar Adam, Caroline M Armet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivoJun Yang, Leonardo V Riella, Susanne Chock, et al.
JCI Insight|November 9, 2021
Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanismsThiago J Borges, Naoka Murakami, Isadora T Lape, et al.
Elife|May 23, 2015
The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cellsBernard Khor, John D Gagnon, Gautam Goel, et al.
Journal of Hematology & Oncology|January 4, 2026
CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignanciesStephen J F Chong, Rebecca Valentin, Jing Wang, et al.
Science (New York, N.Y.)|July 3, 2025
Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognitionGeorg Petzold, Pablo Gainza, Stefano Annunziato, et al.
Pageof 2